Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS, et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med. 2006;203:2485–94.

Article  PubMed  PubMed Central  Google Scholar 

Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–40.

Article  PubMed  Google Scholar 

Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol. 1999;277:C1–9.

Article  PubMed  Google Scholar 

Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521–33.

Article  PubMed  Google Scholar 

Jergens AE. Feline idiopathic inflammatory bowel disease: what we know and what remains to be unraveled. J Feline Med Surg. 2012;14:445–58.

Article  PubMed  PubMed Central  Google Scholar 

Jergens AE, Simpson KW. Inflammatory bowel disease in veterinary medicine. Front Biosci (Elite Ed). 2012;4:1404–19.

Article  PubMed  Google Scholar 

Sabattini S, Bottero E, Turba ME, Vicchi F, Bo S, Bettini G. Differentiating feline inflammatory bowel disease from alimentary lymphoma in duodenal endoscopic biopsies. J Small Anim Pract. 2016;57:396–401.

Article  PubMed  Google Scholar 

Imhann F, Vich VA, Bonder MJ, Fu J, Gevers D, Visschedijk MC, et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2018;67:108–19.

Article  PubMed  Google Scholar 

Guo W, Mao B, Cui S, Tang X, Zhang Q, Zhao J et al. Protective effects of a Novel Probiotic Bifidobacterium pseudolongum on the intestinal barrier of colitis mice via modulating the Ppargamma/STAT3 pathway and intestinal microbiota. Foods. 2022;11.

Zhang B, Chen T, Cao M, Yuan C, Reiter RJ, Zhao Z, et al. Gut Microbiota Dysbiosis Induced by decreasing endogenous melatonin mediates the pathogenesis of Alzheimer’s disease and obesity. Front Immunol. 2022;13:900132.

Article  PubMed  PubMed Central  Google Scholar 

Cui B, Li P, Xu L, Peng Z, Xiang J, He Z, et al. Step-up fecal microbiota transplantation (FMT) strategy. Gut Microbes. 2016;7:323–8.

Article  PubMed  PubMed Central  Google Scholar 

Gotts JE, Abbott J, Matthay MA. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy. Am J Physiol-Lung C. 2014;307:L395–406.

Article  Google Scholar 

Li Y, Altemus J, Lightner AL. Mesenchymal stem cells and acellular products attenuate murine induced colitis. Stem Cell Res Ther. 2020;11:515.

Article  PubMed  PubMed Central  Google Scholar 

Liu A, Liang X, Wang W, Wang C, Song J, Guo J, et al. Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis. Stem Cell Res Ther. 2023;14:271.

Article  PubMed  PubMed Central  Google Scholar 

Zhao X, Liu J, Zhang C, Yu N, Lu Z, Zhang S, et al. Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase. Int J Oral Sci. 2021;13:31.

Article  PubMed  PubMed Central  Google Scholar 

Dias IE, Dias IR, Franchi-Mendes T, Viegas CA, Carvalho PP. A Comprehensive Exploration of therapeutic strategies in Inflammatory Bowel diseases: insights from Human and Animal studies. Biomedicines. 2024;12. 12(4), 735

Cao J, Chen M, Xu R, Guo M. Therapeutic mechanisms of Berberine to improve the intestinal barrier function via modulating gut microbiota, TLR4/NF-kappa B/MTORC Pathway and autophagy in cats. Front Microbiol. 2022;13:961885.

Article  PubMed  PubMed Central  Google Scholar 

Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2010;16:112–24.

Article  PubMed  Google Scholar 

Lautenschlager C, Schmidt C, Fischer D, Stallmach A. Drug delivery strategies in the therapy of inflammatory bowel disease. Adv Drug Deliver Rev. 2014;71:58–76.

Article  Google Scholar 

Chen Y, Liu H, Zhang Q, Luo Y, Wu L, Zhong Y, et al. Cinacalcet targets the Neurokinin-1 receptor and inhibits PKCdelta/ERK/P65 signaling to Alleviate Dextran Sulfate Sodium-Induced Colitis. Front Pharmacol. 2021;12:735194.

Article  PubMed  PubMed Central  Google Scholar 

Shi Z, Takeuchi T, Nakanishi Y, Kato T, Beck K, Nagata R, et al. A Japanese Herbal Formula, Daikenchuto, alleviates experimental colitis by Reshaping Microbial Profiles and Enhancing Group 3 innate lymphoid cells. Front Immunol. 2022;13:903459.

Article  PubMed  PubMed Central  Google Scholar 

Bergmann CA, Beltran S, Vega-Letter AM, Murgas P, Hernandez MF, Gomez L et al. The Autophagy Protein Pacer Positively Regulates the Therapeutic Potential of Mesenchymal Stem Cells in a Mouse Model of DSS-Induced Colitis. Cells-Basel. 2022;11.

Stavely R, Robinson AM, Miller S, Boyd R, Sakkal S, Nurgali K. Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis. Stem Cell Res Ther. 2015;6:263.

Article  PubMed  PubMed Central  Google Scholar 

Fu Y, Zhang C, Xie H, Wu Z, Tao Y, Wang Z, et al. Human umbilical cord mesenchymal stem cells alleviated TNBS-induced colitis in mice by restoring the balance of intestinal microbes and immunoregulation. Life Sci. 2023;334:122189.

Article  PubMed  Google Scholar 

Ocansey D, Wang L, Wang J, Yan Y, Qian H, Zhang X, et al. Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect. Clin Transl Med. 2019;8:31.

Article  PubMed  PubMed Central  Google Scholar 

Shi X, Chen Q, Wang F. Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies. Stem Cell Res Ther. 2019;10:266.

Article  PubMed  PubMed Central  Google Scholar 

Liang J, Zhang H, Wang D, Feng X, Wang H, Hua B, et al. Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease. Gut. 2012;61:468–9.

Article  PubMed  Google Scholar 

Fu Y, Ni J, Chen J, Ma G, Zhao M, Zhu S, et al. Dual-functionalized MSCs that Express CX3CR1 and IL-25 exhibit enhanced Therapeutic effects on Inflammatory Bowel Disease. Mol Ther. 2020;28:1214–28.

Article  PubMed  PubMed Central  Google Scholar 

Huldani H, Margiana R, Ahmad F, Opulencia M, Ansari MJ, Bokov DO, et al. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells. Int Immunopharmacol. 2022;107:108698.

Article  PubMed  Google Scholar 

Dheer R, Davies JM, Quintero MA, Damas OM, Deshpande AR, Kerman DH, et al. Microbial signatures and Innate Immune Gene expression in Lamina Propria phagocytes of Inflammatory Bowel Disease patients. Cell Mol Gastroenter. 2020;9:387–402.

Google Scholar 

Li B, Li X, Chu X, Lou P, Yuan Y, Zhuge A, et al. Micro-ecology restoration of colonic inflammation by in-situ oral delivery of antibody-laden hydrogel microcapsules. Bioact Mater. 2022;15:305–15.

PubMed  Google Scholar 

Ross MC, Muzny DM, McCormick JB, Gibbs RA, Fisher-Hoch SP, Petrosino JF. 16S gut community of the Cameron County Hispanic Cohort. Microbiome. 2015;3:7.

Article  PubMed  PubMed Central  Google Scholar 

Long X, Wong CC, Tong L, Chu E, Ho SC, Go M, et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nat Microbiol. 2019;4:2319–30.

Article  PubMed  Google Scholar 

Zhu L, Zong X, Xiao X, Cheng Y, Fu J, Lu Z, et al. Multi-omics Analysis of the gut-liver Axis reveals the mechanism of Liver Injury in Colitis mice. Front Immunol. 2021;12:773070.

Article  PubMed  Google Scholar 

Li L, Wang M, Chen J, Xu Z, Wang S, Xia X, et al. Preventive effects of Bacillus licheniformis on heat stroke in rats by sustaining intestinal barrier function and modulating gut microbiota. Front Microbiol. 2021;12:630841.

Article  PubMed  PubMed Central  Google Scholar 

Yue Y, Wang Y, Xie Q, Lv X, Zhou L, Smith EE, et al. Bifidobacterium bifidum E3 combined with Bifidobacterium longum subsp. infantis E4 improves LPS-Induced Intestinal Injury by inhibiting the TLR4/NF-kappaB and MAPK signaling pathways in vivo. J Agr Food Chem. 2023;71:8915–30.

Article  Google Scholar